Aduro Biotech, Inc. , a biopharmaceutical company with three distinct immunotherapy technologies, announced data presentations relating to its technology platforms to be given at the 2017 American Association for Cancer Research Annual Meeting taking place in Washington, D.C., April 1 through April 5, 2017. About Aduro Aduro Biotech, Inc. is an immunotherapy company focused on the discovery, development and commercialization of therapies that transform the treatment of challenging diseases.